These side effects were being notably milder in comparison to an inhibitor of the two bromodomains. A detailed molecular analysis also exposed that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen Taylor 88 These preclinical studies present paradigms for foreseeable future clinical trials in AML, and https://abbv-744anditsimpactongen92468.topbloghub.com/38400823/about-abbv-744-as-a-potential-therapeutic-option-for-aggressive-cancers